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http:WHAT THIS PAPER ADDS
The ear is the second most common location of extracranial arteriovenous malformations (AVMs) in the head
and neck. Ethanol embolization has made considerable progress in the management of auricular AVMs. How-
ever, embolization of high-ﬂow auricular AVMs along with a dominant outﬂow vein (DOV) is still challenging to
interventional radiologists. The safety and efﬁcacy of ethanol embolotherapy for high-ﬂow auricular AVMs in
conjunction with electrolytically detachable coil-assisted occlusion of DOV is evaluated.Objectives: High-ﬂow arteriovenous malformations (AVMs) with a dominant outﬂow vein (DOV) remain difﬁcult
for ethanol embolotherapy, but improved technology and experience of detachable coils allows for the treatment
of some of these AVMs with satisfactory results. A single-center experience and evaluation of technical and
clinical safety, and effectiveness of electrolytically detachable coil (EDC)-assisted DOV occlusion for ethanol
embolization of high-ﬂow auricular AVMs, which has some advantages over conventional coils because of its
controlled deployment, reposition, and removal is reported.
Methods: From November 2010 to June 2013, 40 consecutive patients with auricular AVMs underwent staged
ethanol embolizations, of which nine patients’ auricular AVMs with a DOV who had undergone ethanol
embolization of high-ﬂow auricular AVMs in combination with EDCs-assisted DOV occlusion were retrospectively
evaluated. Clinical follow-up (range, 5e29 months; mean, 15.1 months) was completed in all patients, and results
from imaging follow-up (range, 7e25 months; mean, 14.7 months) were available from the last treatment
session in six patients. Therapeutic outcomes were determined by evaluating the clinical outcome of symptoms
and signs, as well as the degree of devascularization at follow-up arteriography.
Results: Twenty-eight ethanol embolizations and nine EDC-assisted DOV occlusions were performed in nine
patients. Seventeen EDCs were used in nine patients. Five (55.6%) of the nine patients were cured, and four
(44.4%) had partial palliation. One minor complication occurred in one of the nine patients. Transient
hemoglobinuria occurred in six of nine patients in a total nine of the 28 procedures. There were no major
complications.
Conclusions: Ethanol embolization has the potential for cure in the management of high-ﬂow auricular AVMs
with the aid of occlusion DOV by EDCs with acceptable risk of minor and major complications.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Arteriovenous malformations (AVMs) are lesions that are
deﬁned by the presence of arteriovenous shunting through
a nidus of coiled and tortuous vascular connections that
connect feeding arteries to draining veins.1 For extracranial
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//dx.doi.org/10.1016/j.ejvs.2014.08.004most common location following the cheek.2,3 The pre-
senting symptoms of auricular AVMs include redness,
swelling, warmth, disﬁgurement, pain, ear noise, infection,
pulsation, bruit, bleeding, tissue ulceration, pruritus, head-
ache, and decreased hearing.3e5 The treatment of auricular
AVMs includes either embolization alone or resection with/
without preoperative embolization. Though amputation is
successful in controlling some auricular AVMs, loss of an ear
is disﬁguring and impairs hearing.3,6,7
Ethanol embolization by the transarterial approach and/
or direct puncture has made considerable progress in the
management of auricular AVMs.4,5 Ethanol embolotherapy
has proved to be curative, even in complex AVMs, by a
Ethanol Embolotherapy of High-ﬂow Auricular AVMs 577combination of a direct denuding effect on the vascular wall
and clumping of damaged erythrocytes and denatured
proteins, which result in complete obliteration of the vessel
lumen.8,9 However, embolization of high-ﬂow auricular
AVMs along with a dominant outﬂow vein (DOV) is still
challenging to interventional radiologists in that injected
ethanol is washed out through the nidus and DOV quickly,
and more ethanol injection is required; the incidence of
complications related to ethanol increases, and more
treatment sessions are needed.
Electrolytically detachable coils (EDCs) are composed of
bare platinum. EDCs have been used to occlude cerebral
aneurysms and offer several favorable design features that
include trackability, softness, low-proﬁle design, radio-
opacity, low thrombogenicity, and retrievability.10 EDCs
have been used in the treatment of vascular lesions
because it is possible to control their deployment, reposi-
tion, and remove them. The purpose of this study was to
assess technical safety, clinical safety, and effectiveness of
ethanol embolization of high-ﬂow auricular AVMs with EDC-
assisted DOV occlusion.
METHODS
Patients
Approval from the institutional review board of the hospital
was obtained for a retrospective review of patient medical
and imaging records, and informed patient consent for the
study was also available. From November 2010 to June
2013, 40 consecutive patients with auricular AVMs under-
went staged ethanol embolizations, of which nine patients
had auricular AVMs with an obvious DOV11,12 where mul-
tiple arteriolar components of the nidus shunted into a
dilated venous component of the nidus that was identiﬁed
as part of a large outﬂow vein on angiography. The patients
who had auricular AVMs with a DOV were suitable for EDC
occlusion before ethanol embolization. The study group
consisted of nine patients (4 males, 5 females) with a mean
age of 36.7 years (age range, 22e60 years) at the time of
treatment. They had been diagnosed as auricular AVMs by
the referring center on the basis of clinical and imaging
ﬁndings. None of the patients had any auricular AVM-
related co-morbidities or any other conditions. Three pa-
tients (patients 4, 6, and 8) had undergone previous partial
resection and n-butyl cyanoacrylate (n-BCA) embolization in
other hospitals before undergoing ethanol embolotherapy.
After intervention, disﬁgurement and symptoms of bleeding
and ear noise became worse.
The obvious dilatation of the external jugular vein was
noted in all patients. The results of audiology assessment
and facial nerve function were normal and symmetric in all
patients. None had vertigo, tinnitus, or conductive hearing
loss. The stage of the AVMs was evaluated according to the
clinical staging system described by Schobinger: stage I
(quiescence): cutaneous blush/warmth; stage II (expansion):
bruit, audible pulsations, expanding lesions; stage III
(destruction): pain, ulceration, bleeding, infection; and
stage IV (decompensation): cardiac failure.2 Selective andsuper-selective DSA, which was required to accurately
deﬁne the feeding arteries, draining veins, and nidus of the
AVMs, was performed in all patients prior to embolization
during the same procedure. The sex and age of the patients,
location of the lesions, previous treatments, clinical ﬁnd-
ings, and Schobinger stages were noted (Table 1).Angiographic and embolization techniques
All procedures were performed by two experienced inter-
ventional radiologists. Nine patients who underwent 28
embolization procedures received general anesthesia with
oral intubation. The arterial pressure, electrocardiogram,
oxygen saturation, and end-tidal carbon dioxide levels were
constantly monitored during the procedure. Pulmonary ar-
tery pressure is not routinely monitored because of high
cost and some catheter-related complications. A Foley
catheter was inserted after induction of anesthesia to
monitor the state of hydration and the possible presence of
hemoglobinuria.
Before the procedure, all patients received an intrave-
nous injection of dexamethasone (usually 10 mg for adults)
to control swelling and accompanying pain. Arteriograms of
both the external carotid artery and the internal carotid
artery were performed. To determine the detailed angio-
architecture of the AVMs, selective angiograms of the
posterior auricular, occipital, and superﬁcial temporal ar-
teries was then performed. Major compartments of the
AVMs and endovascular access to those compartments
were delineated. All angiograms of auricular AVMs showed
tortuous arteriolar components of the nidus, and an
obvious DOV formation (Fig. 1A,B).
Once the large outﬂow vein of the AVMs was noted, the
use of EDC occlusion before ethanol injection was indicated.
After the lesion region was sterilized and draped, an 18G
needle (Cook, Bloomington, IN, USA) was used to percuta-
neously puncture the DOV, then a venogram was taken to
verify the position of the needle in the DOV (Fig. 1C). A 2.1F
microcatheter (Asahi, Seto, Japan) was introduced through
the needle into the dilated venous sac. After conﬁrmation
of the correct position for the microcatheter, a three-
dimensional EDC (Acheva, Shanghai, China) was inserted
into the dilated venous sac through the microcatheter
(Fig. 1D). Digital pressure of the DOV decreased the possi-
bility of migration of the EDCs and helped their conforma-
tion to the dilated vein. The EDCs were retracted and re-
deployed if in an unfavorable position or displaying an un-
favorable conﬁguration. Prior to coil detachment, the coil
conﬁguration was observed under ﬂuoroscopy to determine
any changes that might indicate instability, possibly result-
ing in coil migration. Another percutaneous direct puncture
with an 18G needle was required to reach the same DOV if
the EDCs which had been deployed were at risk of migration
to the systemic circulation because of high-ﬂow in the
draining vein of the AVMs. Then, the initial EDC was not
detached until another EDC had been deployed and coiled
up with the ﬁrst one, so that there was no risk of migration
of either. Following satisfactory placement and observation
Table 1. Demographics and clinical presentation of patients with high-ﬂow auricular arteriovenous malformations.
Patient
no.
Age
(yrs)/Sex
Schobinger
stage
Ear
involved
Clinical manifestations Previous treatment Location of contiguous
soft tissues
1 33/F III L Bleeding, ulceration,
ear noise, pulsation
disﬁguring
None RS
2 28/M II L Disﬁguring, ear noise,
pulsation
None RS þ OS þ TS
3 25/F II R Pulsation, ear noise,
disﬁguring
None OS þ N
4 50/M III L Bleeding, ulceration,
ear noise, disﬁguring,
pain, pulsation
n-BCA embolization
and part resection
RS þ OS
5 59/F III R Bleeding, ear noise,
ulceration, pulsation,
disﬁguring
None RS þ N
6 26/F III L Bleeding, pain, ear noise,
disﬁguring, ulceration,
pulsation
n-BCA embolization
and part resection
RS þ CPG þ TS
7 22/M III L Bleeding, ear noise,
ulceration, disﬁguring,
pulsation
None CPG
8 60/F II R Ear noise, pulsation,
disﬁguring
n-BCA embolization
and part resection
RS þ CPG þ TS
9 27/M III L Bleeding, ear noise,
pulsation, disﬁguring
None TS þ CPG þ OS
RS ¼ retroauricular skin; TS ¼ temporal scalp; CPG ¼ cheek/parotid glands; OS ¼ occipital scalp; N ¼ neck.
578 D. Wang et al.for stability, the coils were detached one by one in the usual
fashion. The pusher wire was then removed under ﬂuoro-
scopic guidance. In all cases, coil size, coil type, and total
number of coils used, were recorded.
After EDC occlusion of DOV, the ﬂow in the lesion was
decreased, and ethanol embolization was begun.4,13 Once
the routes of endovascular access to the lesions were
identiﬁed, a microcatheter (Cordis Endovascular, Miami
Lakes, FL, USA) was introduced into the nidus coaxially. At
times, even these complex maneuvers failed and direct
puncture of the nidus was required. The area of percuta-
neous puncture was prepped and draped. 21G butterﬂy
needles were advanced under the guidance of repeated
contrast injections. Super-selective placement of the cath-
eter tip or the needle tip was a requirement; only then
could ethanol be injected into the nidus with sparing of all
the normal vascular structures (Fig. 2). Ethanol was manu-
ally injected after several arteriograms were performed to
determine an appropriate volume and rate of ethanol in-
jection on the basis of the exact ﬂow characteristics of the
AVMs. Arteriography was performed 5e10 minutes after
each ethanol injection to determine whether thrombosis
had occurred. Meticulous repetition of the previously
described technique was required until complete emboli-
zation of at least one compartment of the AVM was ach-
ieved. The technique is summarized in Fig. 3.
The total amount of absolute ethanol used per session
was less than 1 mL/kg body weight.8,14 Postoperative
management consisted of steroid and intravenous infusion
of ﬂuids. Patients with gastrointestinal tract sensitivity to
steroids were also given ranitidine to protect against gastricor duodenal ulcer development. Hemoglobinuria that
occurred during the procedure was managed by hydration
with intravenously administered Ringer’s solution. The
subsequent medication usually included a tapering dose of
oral methylprednisolone for 7 days to reduce swelling and
ranitidine to prevent ulcer development, if required. Before
patients were discharged, the clinical outcome of symptoms
and signs, as well as the complications, were evaluated.Evaluation of clinical data and follow-up results
Follow-up evaluation was obtained on the basis of physical
examination at 3-month intervals and telephone question-
naires at 1-month intervals in all patients (follow-up range,
5e29 months; mean, 15.1 months) after the initial proce-
dure. Arteriography was performed in six patients (range,
7e25 months; mean, 14.7 months). The hospital stays were
from 3 to 5 days (mean, 3.7 days). Additional embolization
was recommended if the symptoms and signs remained or
if the AVMs were still present at follow-up imaging. The
results were graded on a four-point scale: worse (i.e., AVM
larger); no change (i.e., AVM  49% resolved); improved
(i.e., AVM 50e99% resolved); and cured (i.e., AVM 100%
resolved).5 One oral and maxillofacial surgeon and one
interventional radiologist evaluated by consensus the clin-
ical outcome of symptoms and signs. Cure was deﬁned as
complete resolution of the clinical symptoms and signs,
with 100% devascularization of the AVMs on arteriography
(Fig. 4A,B). Partial palliation was deﬁned as complete res-
olution or improvement of the clinical symptoms and signs,
with 50%e99% devascularization of the AVMs on
Figure 1. (A) Antero-posterior view of an angiogram of the left external carotid artery showing extracranial arteriovenous malformations
(AVMs) (arrowhead) with a dominant outﬂow vein (DOV) (arrow) around the left ear. (B) Lateral view of an angiogram of the left external
carotid artery showing AVMs (arrowhead) with a DOV (arrow) around the left ear. (C) The DOV was demonstrated on the venogram with
the direct puncture approach. (D) Electrolytically detachable coils (arrow) were then released after conﬁrmation of no migration.
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or no change of the clinical symptoms and signs, with less
than 50% devascularization of the AVMs on arteriography.
Aggravation was deﬁned as an aggravation of the clinicalFigure 2. Ethanol was injected into the nidus through puncture
approach after electrolytically detachable coil-assisted dominant
outﬂow vein occlusion and decrease in the ﬂow from the high-ﬂow
drainage vein.
Figure 3. Schematic depiction of treatment of auricular extracra-
nial arteriovenous malformations with a dominant outﬂow vein.
Figure 4. (A) Final postero-anterior view of the external carotid artery angiogram showing obliteration of arteriovenous malformations
(AVMs) of the left ear. (B) Final lateral view of the external carotid artery angiogram showing obliteration of AVMs of the left ear. (C) The
lateral view of the left ear before treatment shows AVMs with a dominant outﬂow vein (DOV). (D) The lateral view of the left ear after
ethanol embolotherapy of AVMs with EDC-assisted DOV occlusion.
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devascularization on arteriography. Cure and partial pallia-
tion were considered effective therapeutic outcomes of
ethanol embolization of the AVMs.8
Complications were classiﬁed into major and minor ones
according to standards reported by the Society of Inter-
ventional Radiology.15 Minor complications were deﬁned as
those that required no management and resulted in no
consequences. Major complications included those that
required therapy or caused permanent adverse sequelae or
death. When complications were observed, the angiograms
were reviewed again to detect the possible cause.RESULTS
Patients and angiogram
All the patients had complex symptoms. Six patients
(66.7%) complained of bleeding. The most common pre-
senting symptoms reported were disﬁgurement and ear
noise, occurring in all patients (100%). According to the
signs and symptoms found from the clinical examination,
the Schobinger stage at initial presentation was stage II in
three patients (33.3%) and stage III in six patients (66.7%).Super-selective angiography demonstrated that the super-
ﬁcial temporal (n ¼ 7), posterior auricular (n ¼ 4), and
occipital arteries (n ¼ 3) on the ipsilateral side of the lesions
were the main feeders of the AVMs. Clinical and imaging
examinations revealed that the AVMs of the contiguous soft
tissues were often located in the retro-auricular skin
(n ¼ 6), cheek/parotid glands (n ¼ 4), neck (n ¼ 2), tem-
poral scalp (n ¼ 4), and occipital scalp (n ¼ 4). In no pa-
tients was there evidence of involvement of the mandible,
external auditory canal, or middle or inner ear.Occlusion of DOV with EDCs
Nine EDC-assisted DOV occlusions were performed after
identifying a large outﬂow vein. In total seventeen 0.018-
inch three-dimensional EDCs of 20 mm in unconstrained
diameter and 30 cm in stretched length were used to
occlude DOV. For one patient (patient 4), the AVMs with a
larger outﬂow vein where EDC occlusion was not adequate
via a single percutaneous direct puncture approach and
where EDC systemic migration circulation was prevented,
EDC placement in the outﬂow vein via another direct
puncture was performed and the EDC was coiled up with
the ﬁrst one in order to reduce the risk of coils being
Ethanol Embolotherapy of High-ﬂow Auricular AVMs 581dragged into systemic circulation prior to ethanol injection.
For others, no migration or deployment problems were
encountered. No immediate complications were related to
the occlusion procedures of the DOV.Outcome of ethanol embolization of auricular AVMs
During the 28 ethanol embolization procedures performed in
nine patients, the amount of ethanol used ranged from 23 to
60 mL, which did not exceed 1 mL/kg body weight in a single
embolization session. Nine patients (100%) with 28 pro-
cedures (100%) exhibited focal swelling in the area of the
AVMs after the procedure, which resolved within 2 weeks.
In regard to the clinical outcome, control of ear noise (9/9
patients), ulceration (5/5 patients), hemorrhage (6/6 pa-
tients), pain (2/2 patients), and pulsation (7/9 patients) was
obtained after ethanol embolization. The alleviation of
redness, swelling, warmth, and disﬁgurementwas achieved in
all patients. In six patients with Schobinger stage III lesions at
initial presentation, postoperative assessment showed that
four patients (66.7%) had improved to stage I, and two pa-
tients (33.3%) to stage II. One patient with preoperative stage
II disease had improved to stage I after ethanol embolization,
and two patients with preoperative stage II lesion remained
stable. According to the angiographic ﬁndings, AVMs were
100% devascularized in ﬁve patients (55.6%), 76% to 99% in
three (33.3%), and 50% to 75% in one (11.1%).
Ethanol embolization of high-ﬂow auricular AVMs with
DOV occlusion assisted by EDCs achieved an effective
therapeutic outcome in all nine patients (Table 2). Five
(55.6%) of the nine patients were cured, and there was no
evidence of recurrence at imaging and/or clinical follow-up.
Four (44.4%) of the nine patients were improved with
clinical symptoms and signs completely resolved and 50e
99% of the AVMs devascularized. Four patients with
improvement, in whom clinical symptoms and signs
remained, were observed and had further sessions of
ethanol embolization to treat the residual AVMs, as
required.Complications
There were no major complications with these procedures.
All patients had blistering immediately after treatment,Table 2. Result of ethanol embolization and electrolytically detachab
arteriovenous malformation patients.
Patient no. No. of procedures No. of
EDCs used
Feeding arteries
1 2 (DP þ CR) 1 STA
2 4 (3DP þ CR) 2 STA þ PAA
3 1 (DP) 1 OA
4 4 (4DP) 2 STA þ OA
5 3 (2DP þ CR) 1 PAA
6 5 (4DP þ CR) 3 STA þ PAA
7 2 (2DP) 1 STA
8 5 (5DP) 4 STA þ PAA þ OA
9 2 (2DP) 2 STA
STA ¼ superﬁcial temporal artery; PAA ¼ posterior auricular artery; Owhich recovered spontaneously in 1 week. One patient
(patient 4; 11.1%) experienced superﬁcial skin necrosis that
healed spontaneously after 4 weeks, without remaining
tissue defect. Transient hemoglobinuria occurred in six
(66.7%) of the nine patients in a total 9 (32.1%) of 28
procedures and disappeared approximately 5e6 hours after
continuous infusion of Ringer’s lactate intravenously.
DISCUSSION
Although a few studies have described embolization of
auricular AVMs,3e5 little interest has been shown in the
role of absolute ethanol and EDC application. In the pre-
sent study, super-selective coaxial or direct puncture
catheterization and ethanol embolization in conjunction
with DOV occlusion of EDCs were safe and effective in the
treatment of auricular AVMs. Because of its satisfactory
outcome, this technique of EDC occlusion of a DOV can
also be used for the treatment of AVMs in other extra-
cranial locations.
AVMs with a DOV are found in about 4e20% of
AVMs.11,12,16,17 and the incidence of AVM with a DOV was
22.5% (9 of 40 cases) in this study. AVMs most commonly
occur in the head and neck, of which the ear is the second
most common location.3 Treatment consists of emboliza-
tion, resection, or a combination of the two.18 Wu et al.
recommend annual assessment for patients with stage I to
II auricular AVMs, especially during childhood. Intervention
is considered whenever there is progression to stage III.3
Embolization can diminish signs and relieve symptoms,
often resulting in downstaging of the Schobinger status.19
Some authors have reported “cure” with selective emboli-
zation using ethanol.4,5,14,20,21 However, cure with emboli-
zation alone is difﬁcult. Because auricular AVMs involve all
arterial branches within the affected pinna, sparing of
normal nutrient vessels is unlikely.3
In the authors’ experience, the preferred treatment is
ethanol embolization of auricular AVMs for the manage-
ment of these extremely complex and challenging lesions.
As the safe limit of a total ethanol dose is 1 mL/kg in one
session, multiple procedures may be required in order to
achieve satisfactory results. The maximum dose of 1 mL/kg
weight should not be exceeded in any single session
because of the toxic effect of ethanol, which may increasele coil occlusion of dominant outﬂow vein in high-ﬂow auricular
Volume of
ethanol (mL)
Clinical
follow-up
(mo)
Clinical outcome DSA
follow-up
(mo)
46/32 15 Cure 13
50/46/38/23 29 Partial palliation 25
40 13 Cure 8
52.5/37/51/43 26 Cure 21
60/56/41 19 Partial palliation 14
52.5/58/43/30/37 11 Partial palliation 7
38/42 5 Cure e
46/32/46/55/37.5 8 Partial palliation e
55/46 10 Cure e
A ¼ occipital artery; DP ¼ direct puncture; CR ¼ coaxial route.
582 D. Wang et al.the risk of pulmonary vasospasm, cardiac arrhythmias, and
cardiopulmonary collapse.14
AVMs containing a DOV were effectively treated by the
use of ethanol in conjunction with coil and/or core-removed
guidewire embolization.16 In the present study, it was found
that ethanol is safe and effective for embolization of high-
ﬂow auricular AVMs with a DOV under the help of EDC
ﬁlling (Fig. 4C,D). EDCs, as detachable coils, were ﬁrst used
in a brain aneurysm after satisfactory animal experimental
results.22,23 The detachable coils have been used in embo-
lization of pulmonary AVMs with a DOV or dilated venous
sac.24,25 In this study, the primary intention of occlusion of
the DOV with EDCs was not to occlude the DOV itself. EDCs
were placed where they would ultimately be depositedFigure 5. A 25-year-old woman with right ear arteriovenous malform
enlarged right ear with pulsatile masses and disﬁgurement. (C,D) Ph
electrolytically detachable coil-assisted dominant outﬂow vein occlusiothrough direct puncture of the DOV as close to the nidus as
possible before ethanol injection. The advantages of EDC
embolization of a DOV are that EDCs could generally be
predictably deposited at the desired site and could be
observed prior to detachment, to help ensure that the coils
were in a secure position, decreasing the chances of unin-
tended passage into the venous outlet. In addition, EDC
placement into the DOV can reduce the rate and volume of
blood ﬂow within the venous component of the nidus,
thereby reducing the amount of ethanol required. In addi-
tion, EDCs are three-dimensional coils with an intrinsic
shape that will seek to retain a spherical overall conﬁgu-
ration when fully deployed. It is likely that these three-
dimensional framing coils resulted in fewer attempts atations (AVMs) (patient 3). (A,B) Pre-operative photographs show
otographs 8 months after ethanol embolotherapy of AVMs with
n, showing shrinkage of the ear with no symptoms.
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after detachment, leading to a signiﬁcant reduction in the
time and ﬂuoroscopy needed to occlude it. Finally, ethanol
embolization of high-ﬂow auricular AVMs with EDC occlu-
sion of the DOV may reduce the number of treatment
sessions for patients with complicated lesions. Retrograde
coil venous embolization of AVMs was ﬁrst described by
Yakes et al.21 and also reported by Jackson et al.11 and Cho
et al.16
There were no perioperative complications during EDC
placement of the DOV in the present study. The risk of
migration of coils, even using detachable ones, ranges from
0.7% to 4%, particularly in cases of high-ﬂow malformations
with large outﬂow vessels.25e27 The most common
complication of ethanol embolization was skin blistering.
Hemoglobinuria secondary to hemolysis was observed in
16.7e28% of patients,28,29 however, 66.7% of patients
developed hemoglobinuria because of the large amount of
ethanol used in this series. There were no patients with
renal impairment resulting from hemoglobinuria in whom
hydration was performed.
This study has some limitations. First, it is retrospective
with a small number of patients and the follow-up duration
was not long enough. There is a need for a prospective
study involving a signiﬁcantly large patient population,
which would permit assessment that is more precise. Sec-
ond, EDCs, as foreign bodies, may cause foreign body re-
actions and interfere with follow-up by computed
tomography and magnetic resonance imaging due to ghost
images. Another drawback of the use of EDCs is their high
cost versus the cost of stainless-steel coils.
In conclusion, initial results show that ethanol embolo-
therapy is safe and effective for high-ﬂow auricular AVMs in
conjunction with EDC-assisted occlusion of the DOV (Fig. 5).
Future studies that incorporate wider multicenter experi-
ence with ethanol embolization of high-ﬂow auricular AVMs
via EDC placement into the DOV are needed to conﬁrm the
value of this technique.CONFLICT OF INTEREST
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